Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)
| 11.49 Delayed Data As of May 26 |  -0.105 / -0.91%Today’s Change | 6.15 Today|||52-Week Range 22.11 | -38.25% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -20.2M | -18.1M | -18.4M | -34.0M | |
| Depreciation | 34.5K | 43.4K | 45.7K | 38.0K | ||
| Total Other Cash Flow | 1.5M | 949.9K | 2.6M | 3.6M | ||
| Funds From Operations | -18.7M | -17.1M | -15.8M | -30.4M | ||
| Funds From/For Other Operating Expenses | -662.8K | 884.4K | -2.0M | -4.7M | ||
| Net Cash Flow - Operating Activities | -18.0M | -18.0M | -13.7M | -25.7M | ||
| Investing | Increase In Investments | -1.8K | -68.6K | -4.0K | -36.8M | |
| Decrease In Investments | 18.8K | 3.7M | 0.00 | 21.4M | ||
| Capital Expenditures | -23.5K | -96.1K | 0.00 | -92.0K | ||
| Net Cash Flow Investing | -6.5K | 3.6M | -4.0K | -15.5M | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Proceeds Stock Sale | 37.2M | 80.3K | 57.4M | 297.6K | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | -- | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 11.3K | 0.00 | 4.4K | ||
| Net Cash Flow - Financing | 37.2M | 69.0K | 57.4M | 293.1K | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | 19.1M | -14.3M | 43.6M | -40.9M | ||
